Algeria vs Bhutan: Cause of death, by non-communicable diseases, ages 0-4, male
Algeria
24.3%
in 2021
Bhutan
24.2%
in 2021
Algeria rank
114th
Bhutan rank
115th
Cause of death, by non-communicable diseases, ages 0-4, male over time
- Algeria
- Bhutan
How they compare
Algeria currently reports 24.3% against 24.2% in Bhutan, a difference of 0.1%.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 114th and Bhutan ranks 115th of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.0% | 8.4% | 7.6% | Algeria |
| 2010s | 24.0% | 17.2% | 6.8% | Algeria |
| 2020s | 24.4% | 23.7% | 0.7% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, male, Algeria or Bhutan?
- Algeria, at 24.3% against 24.2% in Bhutan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, male between Algeria and Bhutan?
- 0.1%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Bhutan?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Bhutan rank globally for cause of death, by non-communicable diseases, ages 0-4, male?
- Algeria ranks 114th and Bhutan ranks 115th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, male (% of total male deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of male deaths ages 0-4 due to non-communicable diseases divided by number of all male deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.